secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2021-08-04T23:59:59+00:00
Accession:  0001104659-21-099777
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two directors resign from EyeGate board effective August 3, 2021
----------------------------------------------------------------

- I. Keith Maher, MD and Steven Boyd resigned from the Board on August 3, 2021, effective immediately.
- Resignations were not due to any disagreements with the Company's operations, policies, or practices.
- No replacements were announced on the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/0001104659-21-099777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/tm2124037-1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-099777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer